| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.10B | +6.5% |
| R&D Expense | $371.0M | +8.2% |
| SG&A Expense | $2.23B | +7.3% |
| Operating Income | $113.0M | -30.2% |
| Interest Expense | $421.0M | +5.5% |
| Pre-tax Income | -$317.0M | -35.5% |
| Income Tax | $35.0M | -50.7% |
| Net Income | -$360.0M | -13.6% |
| EPS (Basic) | -$1.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $383.0M | +25.6% |
| Accounts Receivable | $1.22B | +19.0% |
| Inventory | $976.0M | -5.8% |
| Current Assets | $2.98B | +6.8% |
| Total Assets | $14.02B | +4.1% |
| Current Liabilities | $1.92B | +10.5% |
| Long-term Debt | $5.05B | +5.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $283.0M | +22.0% |
| Capital Expenditures | $349.0M | +19.9% |
| Investing Cash Flow | -$455.0M | -10.4% |
| Financing Cash Flow | $225.0M | +26.4% |
| Free Cash Flow | -$66.0M | -11.9% |
| -13.3% |
| EPS (Diluted) | -$1.02 | -13.3% |
| Total Liabilities |
| $7.50B |
| +8.3% |
| Stockholders' Equity | $6.45B | -0.4% |